Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Celularity Inc. specializes in regenerative and cellular medicines derived from placental tissue, developing off-the-shelf allogeneic cell therapies and advanced biomaterials. Its core offerings include placental-derived cell products, biomaterials for wound and tissue repair, and biobanking services. The company targets aging-related, degenerative, and immune disorders, leveraging proprietary manufacturing platforms and extensive IP to deliver scalable, accessible therapies and contract manufacturing solutions worldwide.
This description was generated via AI from an annual report. Updated about 1 year ago.